SOLACUTAN gel 3 % tb 25 g

7680666440018 CH-66644 D11AX18 10.99.0.
SOLACUTAN gel 3 % tb 25 g
SOLACUTAN gel 3 % tb 25 g
SOLACUTAN gel 3 % tb 25 g
1 / 3
google

Details

Product number
6664401
CPT
-
Packaging group
25
Unit
g
Composition
diclofenacum natricum 30 mg, natrii hyaluronas, macrogolum 400, aqua purificata, alcohol benzylicus 15 mg, ad gelatum pro 1 g.

Articles (1)

Solacutan 3%, Gel
Gel
25
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
16/03/2021
Patient information leaflet
Français
16/03/2021
Patient information leaflet
Italien
16/03/2021
Professional SmPC
Allemand
16/03/2021
Professional SmPC
Français
16/03/2021
Professional SmPC
Italien
16/03/2021

Detailed composition

Substance Quantity Type Category
(N/A)
30.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
15.0 MG Substance HBESI

Reimbursement information

Public price
CHF 30.85
Specialties list
Yes
Generic
Yes
SL addition date: 01/10/2018

Authorization holder

Dermapharm AG

6331 Hünenberg

Authorization information

Swissmedic authorization number
66644
Drug name
Solacutan 3%, Gel
Galenic form
GELK
ATC Code
D11AX18
Authorization status
Z
Dispensation category
B
First authorization
12/03/2018
Authorization expiration date
31/12/9999
IT number
10.99.0.
Domain
Human medicine
Field of application
Behandlung aktinische Keratose

Packaging details

Description (FR)
SOLACUTAN gel 3 % tb 25 g
Description (DE)
SOLACUTAN Gel 3 % Tb 25 g
Market launch
12/03/2018
Narcotic (BTM)
No

Original drug

Solaraze 3%, Gel
CHF 46.05
View original

Other packaging sizes

SOLACUTAN gel 3 % tb 50 g
50 G
View